O-7460
O-7460 is a potent and selective DAGLα inhibitor, with an IC50 of 0.69 μM. O-7460 shows selectivity over onoacylglycerol lipase (MAGL), human CB1 and CB2 cannabinoid receptors. O-7460 can decrease HFD-caused an up-regulation of 2-AG levels[1].
Product Specifications
CAS Number
1572051-31-0
UNSPSC
12352211
Hazard Statement
H225-H319-H336
Target
Cannabinoid Receptor; DAGL
Type
Reference compound
Related Pathways
GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/o-7460.html
Concentration
10.45 mM * 100 μL in Methyl acetate
Purity
95.0
Solubility
10 mM in DMSO
Smiles
CC(OCC(COP(F)(C)=O)OC(CCCCCCC/C=C\CCCCCCCC)=O)C
Molecular Formula
C25H48FO5P
Molecular Weight
478.62
Precautions
P210-P233-P240-P241-P242-P243-P261-P264-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P370+P378-P403+P233-P403+P235-P405-P501
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
Solution, -20°C, 2 years
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
DAGLα
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Burkholderia mallei Polyribonucleotide nucleotidyltransferase (pnp), partial
![Mouse Monoclonal Dystrophin Antibody (DMD/3244) [Biotin]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
Mouse Monoclonal Dystrophin Antibody (DMD/3244) [Biotin]